Abstract | OBJECTIVE: To establish whether the combination of cognitive-behavioral therapy (CBT) and pharmacotherapy (SSRI) was more effective in treating panic disorder (PD) than either CBT or SSRI alone, and to evaluate any differential effects between the mono-treatments. METHOD: Patients with PD (n = 150) with or without agoraphobia received CBT, SSRI or CBT + SSRI. Outcome was assessed after 9 months, before medication taper. RESULTS: CBT + SSRI was clearly superior to CBT in both completer and intent-to-treat analysis (ITT). Completer analysis revealed superiority of CBT + SSRI over SSRI on three measures and no differences between CBT and SSRI. ITT analysis revealed superiority of SSRI over CBT on four measures and no differences between CBT + SSRI and SSRI. CONCLUSION: Both the mono-treatments (CBT and SSRI) and the combined treatment (CBT + SSRI) proved to be effective treatments for PD. At post-test, CBT + SSRI was clearly superior to CBT, but differences between CBT + SSRI and SSRI, and between SSRI and CBT, were small.
|
Authors | F J van Apeldoorn, W J P J van Hout, P P A Mersch, M Huisman, B R Slaap, W W Hale 3rd, S Visser, R van Dyck, J A den Boer |
Journal | Acta psychiatrica Scandinavica
(Acta Psychiatr Scand)
Vol. 117
Issue 4
Pg. 260-70
(Apr 2008)
ISSN: 1600-0447 [Electronic] United States |
PMID | 18307586
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Serotonin Uptake Inhibitors
|
Topics |
- Adolescent
- Adult
- Agoraphobia
(drug therapy, therapy)
- Anxiety Disorders
(diagnosis, therapy)
- Cognitive Behavioral Therapy
(methods)
- Combined Modality Therapy
- Female
- Humans
- Male
- Middle Aged
- Panic Disorder
(diagnosis, drug therapy, therapy)
- Selective Serotonin Reuptake Inhibitors
(therapeutic use)
- Severity of Illness Index
- Surveys and Questionnaires
- Treatment Outcome
|